the adrenal function was assessed before treatment and at the end of the 4th month of therapy , evaluating the peripheral plasma concentrations of pregnenolone ( delta 5p ) , progesterone , 17-oh-progesterone , dehydro-epiandrosterone sulfate , androstenedione , testosterone , and cortisol in basal conditions and after dexamethasone suppression and an adrenocorticotropic hormone ( acth ) stimulation test .
C0033308
progesterone
C0020387
17-oh-progesterone